We derive new estimators of an optimal joint testing and treatment regime
under the no direct effect (NDE) assumption that a given laboratory,
diagnostic, or screening test has no effect on a patient’s clinical outcomes
except through the effect of the test results on the choice of treatment. We
model the optimal joint strategy using an optimal regime structural nested mean
model (opt-SNMM). The proposed estimators are more efficient than previous
estimators of the parameters of an opt-SNMM because they efficiently leverage
the no direct effect (NDE) of testing' assumption. Our methods will be of importance to decision scientists who either perform cost-benefit analyses or are tasked with the estimation of the value of information’ supplied by an
expensive diagnostic test (such as an MRI to screen for lung cancer).

生成讲解博客的中文版本

生成AI智能校验的中文版本